+86 16650237703
Author:Kangdi 30-09-2026
Pain Patch OEM Private Label vs White Label vs Contract Manufacturing 2026: Which Model Fits Your Brand?
Target audience: Pain patch brand owners, e-commerce sellers, and distributors deciding whether to launch a private label, white label, or fully custom contract manufacturing programme in 2026.
Reading time: 16 minutes. Author: Kangdi Medical — 37+ years OEM/ODM manufacturer, ISO 13485 / CE / FDA / GMP certified, daily capacity 4,000,000 patches.
Last updated: 2026-09-30. Coverage: what each model actually means in practice, the real difference in cost and control, minimum order quantities, who holds the registration, packaging and IP ownership, the right model for each brand stage, and how to transition between models without losing your market position.
Quick answer: The three models differ on one axis that matters more than everything else — who controls the product and the registration. White label means you resell an existing formulation under your own brand (lowest cost and fastest launch, but the factory can sell the identical product to your competitors tomorrow). Private label means a formulation configured for you, with your branding and packaging (moderate cost, meaningful differentiation, typically 5,000–10,000 patch MOQ). Contract manufacturing means you own the formulation, the tooling, and the technical file (highest cost and longest lead time, but defensible and registrable in your own name). For most first-time brands the pragmatic sequence is white label to validate demand, private label to build margin, and contract manufacturing once revenue justifies the investment. Choosing the wrong starting model is the most expensive mistake in this category because switching later means new tooling, new artwork, and in most markets a new regulatory submission.
Table of Contents
- The Three Models at a Glance
- What Each Model Actually Means in Practice
- Model 1: White Label
- Model 2: Private Label
- Model 3: Contract Manufacturing
- Side-by-Side: Cost, Control, Speed and Risk
- Minimum Order Quantities by Model
- Cost Structure and Margin Comparison
- Who Owns the Packaging and Artwork
- Regulatory Registration: Who Holds What
- Which Model Fits Which Brand Stage
- Transitioning Between Models
- Seven Mistakes That Cost Brands a Year
- FAQ: Private Label vs White Label vs Contract Manufacturing
1. The Three Models at a Glance
| Dimension | White Label | Private Label | Contract Manufacturing |
|---|---|---|---|
| Formulation | Factory's existing recipe | Factory's recipe, configured to your specification | Yours, developed with or for you |
| Differentiation | Minimal | Moderate | High |
| Typical MOQ | 500–2,000 patches | 5,000–10,000 patches | 10,000–50,000 patches |
| Tooling and artwork cost | Low (stock artwork adapted) | USD 1,500–4,000 | USD 4,000–15,000 |
| Time to first shipment | 2–4 weeks | 5–8 weeks | 10–20 weeks |
| Who owns the technical file | Factory | Shared or factory | You |
| Registrable in your name | Rarely | Often, with agreement | Yes |
| Can the factory sell to competitors | Yes, immediately | Only if the configuration is not protected | No, if exclusivity is contracted |
The one question that determines your model choice: if your supplier sold the identical product to a competitor next quarter, would your business survive? If the answer is no, you are not ready for white label. If yes, white label is an efficient way to validate a market before investing further.
2. What Each Model Actually Means in Practice
The three terms are used loosely across the industry, which creates expensive misunderstandings. Here is what each means in operational reality.
| Term | What the Factory Provides | What You Provide | What You Actually Buy |
|---|---|---|---|
| White label | Finished product, existing formulation, adapted stock packaging | Brand name on the label | A branded box containing someone else's product design |
| Private label | Industrial capacity plus configuration flexibility | Specification choices, artwork, packaging design, market positioning | A product configured for your market, on shared process infrastructure |
| Contract manufacturing | Capacity, engineering, quality systems, regulatory documentation | Formulation ownership, tooling investment, technical file | Your product, produced on someone else's line |
The practical distinction most buyers miss: white label and private label both use the factory's underlying recipe. Contract manufacturing is the only model where the recipe itself is yours. Everything else is a difference of degree in packaging, configuration, and exclusions.
Why this matters commercially: if your product's value proposition rests on the formulation, only contract manufacturing protects it. If your value proposition rests on brand, distribution, or service, white label and private label can support a strong business — provided you understand the exposure.
3. Model 1: White Label
White label is the fastest and cheapest entry. You buy finished goods from a factory's existing range, apply your brand, and sell.
What white label looks like in practice:
- The formulation is one the factory already produces at volume — typically a standard menthol, camphor, capsaicin or methyl salicylate patch
- Packaging starts from an existing box or pouch design with your logo and brand colours applied
- Production scheduling is easier because your order slots into an existing run
- Documentation is usually the factory's existing set, with your brand added to the artwork
| Advantage | Limitation |
|---|---|
| Lowest entry cost in the category | Identical or near-identical product available to competitors |
| Launch in 2–4 weeks | No formulation control and no formulation exclusivity |
| Proven formulation with existing stability data | Limited pricing power — buyers can often find the same item |
| Low MOQ, low inventory risk | Artwork usually remains close to the factory's stock design |
| Fast learning cycle on real marketplace feedback | Registration typically stays in the factory's or an intermediary's name |
When white label is the right answer: you are testing whether a market exists before committing capital; you have distribution strength and the product itself is not your differentiator; or you need revenue in the current quarter and cannot wait for a longer development cycle.
The specific risk to price correctly: because the product is widely available, white label margins compress quickly once a category becomes competitive. Model the margin at the price a competitor could reach if they bought the same item, not at today's price. That is your realistic floor.
4. Model 2: Private Label
Private label sits between the extremes. You configure a product within the factory's capability — active concentrations, patch size and shape, adhesive system, pack count, scent, packaging format — and sell it under your own brand on your own artwork.
What you can actually change in a private label programme:
| Element | Typically Changeable | Usually Fixed |
|---|---|---|
| Active ingredient combination | Within the factory's approved range | Novel actives outside the range |
| Active concentration | Within monograph limits | Concentrations requiring new safety data |
| Patch dimensions and shape | Most sizes and shapes | Non-standard formats needing new tooling |
| Adhesive and backing | Standard options | Custom polymers |
| Pack count and format | Multiple pack sizes | Unusual formats needing new tooling |
| Packaging design and artwork | Fully yours | Nothing — artwork is yours |
| Formulation ratios | Sometimes, by agreement | Proprietary ratios held by the factory |
The key benefit: private label gives you a product that looks and behaves distinctly from competitors on the shelf, at a fraction of contract manufacturing cost, because the factory's existing process platform and stability programme are reused.
The key limitation: the underlying formulation is still not exclusively yours. Two brands can run different packaging, different patch dimensions and different pack counts while using the same base recipe. Consumers may not notice the difference, and you cannot prevent it contractually in most cases.
MOQ reality: private label MOQs are usually driven by packaging tooling rather than production. A print plate for a custom box typically requires 5,000 units to amortise sensibly. If you can accept a stock pouch with custom outer box, the MOQ can sometimes fall to 2,000–3,000 units.
5. Model 3: Contract Manufacturing
Contract manufacturing is the model where you own the product. You commission development, own the formulation and technical file, invest in tooling, and typically secure exclusivity for your market.
| What You Own | Why It Matters | Typical Cost |
|---|---|---|
| Formulation and ratios | No competitor can produce the identical product | USD 3,000–12,000 development |
| Technical file | You can register in your own name in any market | Included in development or USD 2,000–5,000 |
| Tooling and print plates | Portable to another factory if needed | USD 2,000–8,000 |
| Artwork and photography | Full brand asset ownership | USD 1,500–6,000 |
| Stability data on your formulation | Supports your regulatory claims directly | USD 2,500–4,000 |
| Market exclusivity, by contract | Prevents direct supply to your competitors | Negotiated, sometimes volume-linked |
The trade-off: contract manufacturing requires 10,000–50,000 unit MOQs in most cases, a 10–20 week development and production cycle, and upfront investment of USD 10,000–35,000 before the first saleable unit exists. It is the right answer only when the volume is real or the differentiation is genuinely defensible.
The one contractual clause that makes it work: exclusivity must be explicit and market-scoped. "We will not produce your formulation for others in your territory" is what converts a contract manufacturing relationship into a defensible position. Without that clause, you have paid for development and still face copy supply.
When it pays back: at volumes above roughly 50,000 patches per year, the formulation and packaging differentiation typically supports a 15–30% retail price premium over white label equivalents. That premium, multiplied across volume, usually repays the development investment within 12–18 months.
6. Side-by-Side: Cost, Control, Speed and Risk
| Factor | White Label | Private Label | Contract Manufacturing |
|---|---|---|---|
| Upfront investment before first sale | USD 1,500–5,000 | USD 6,000–15,000 | USD 10,000–35,000 |
| Unit cost (box of 5, at MOQ) | USD 0.90–1.40 | USD 1.10–1.80 | USD 1.30–2.20 |
| Achievable retail price | USD 9–14 | USD 13–19 | USD 16–26 |
| Gross margin potential | 35–45% | 45–58% | 55–70% |
| Time to first shipment | 2–4 weeks | 5–8 weeks | 10–20 weeks |
| Product differentiation | Low | Medium | High |
| Registration in your own name | Rarely | Often | Yes |
| Exposure to copy supply | High | Medium | Low, if exclusive |
| Complexity of management | Low | Medium | High |
| Ability to switch supplier later | Easy | Moderate | Difficult without tech transfer |
The margin-versus-risk relationship: gross margin rises steadily across the three models, but so does the cost of being wrong. A white label mistake costs a few thousand dollars and a relaunch. A contract manufacturing mistake costs tens of thousands and the better part of a year.
The practical implication: match the model to your confidence level, not to your ambition. Brands that jump straight to contract manufacturing without marketplace evidence frequently fund a bespoke product for a market that does not want it.
7. Minimum Order Quantities by Model
| Model | Typical MOQ | What Drives the MOQ | How to Reduce It |
|---|---|---|---|
| White label | 500–2,000 patches | Minimum run efficiency and stock packaging availability | Accept stock pouch and stock box with a sticker or label |
| Private label, stock packaging | 2,000–5,000 patches | Print plate amortisation | Use a standard pouch with a custom outer box only |
| Private label, full custom packaging | 5,000–10,000 patches | Pouch and box tooling plus print plates | Combine multiple SKUs into one tooling run |
| Contract manufacturing | 10,000–50,000 patches | Development effort amortisation and line changeover | Negotiate a staged commitment with volume milestones |
The MOQ negotiation that works: offer a staged commitment. "5,000 units in the first order, 15,000 across the first twelve months" is a credible proposition that many factories accept at a lower first-order quantity than a flat 10,000-unit demand, because the annual volume is what matters to their planning.
What never works: asking for 1,000 units of a fully custom formulation with custom tooling and custom packaging. The tooling and development costs cannot be recovered at that volume, so the factory either declines or prices it so high that the economics collapse.
8. Cost Structure and Margin Comparison
| Cost Line | White Label | Private Label | Contract Manufacturing |
|---|---|---|---|
| Formulation development | 0 | 0–2,000 | 3,000–12,000 |
| Tooling and print plates | 0–600 | 1,500–4,000 | 4,000–15,000 |
| Artwork and design | 200–800 | 1,000–3,000 | 1,500–6,000 |
| Third-party lab testing | 0 (reuse factory data) | 1,500–4,200 | 2,500–6,000 |
| Stability study | 0 (reuse factory data) | 0–4,000 | 2,500–4,000 |
| First production order | 500–2,800 | 5,500–18,000 | 13,000–44,000 |
| Total to first sale | USD 1,500–5,000 | USD 6,000–15,000 | USD 10,000–35,000 |
| Unit cost (box of 5) | 0.90–1.40 | 1.10–1.80 | 1.30–2.20 |
| Gross margin at retail | 35–45% | 45–58% | 55–70% |
| Payback at 30,000 boxes/year | 1–3 months | 3–7 months | 7–18 months |
Read the last row carefully. The payback comparison looks unfavourable to contract manufacturing, and at low volume it genuinely is. The advantage appears only at scale: at 30,000 boxes per year, the 10–15 percentage point margin difference represents USD 3,000–7,000 of additional annual gross profit — which repays development in roughly two to four years. At 100,000 boxes per year, it repays in under twelve months.
The volume threshold to remember: below about 30,000 boxes per year, private label usually beats contract manufacturing on return on capital. Above about 60,000 boxes per year, contract manufacturing usually wins. Between the two, the deciding factor is whether your differentiation claim requires formulation exclusivity.
9. Who Owns the Packaging and Artwork
| Asset | White Label | Private Label | Contract Manufacturing |
|---|---|---|---|
| Box artwork files | Factory owns the template, you own your logo layer | You own the design, subject to the factory's base template rights | You own outright |
| Print plates | Factory's property | Usually yours if you paid for them — confirm in writing | Yours |
| Patch dimensions and format | Factory's | Often shared | Yours |
| Photography | Factory's stock imagery | Yours if commissioned | Yours |
| Copy and claims | Adapted from factory material | Yours, subject to regulatory review | Yours |
| Registration dossier | Factory's | Shared, or transferred by agreement | Yours |
The clause that protects you in private label: state explicitly that print plates, tooling and artwork files are your property, that they must be returned or destroyed on termination, and that the factory may not reuse them for any other customer. Without that clause, paid-for tooling frequently remains usable by the factory for other brands.
Photography and copy: if you commission product photography, ensure the photographer assigns copyright to you in writing. Stock imagery licensed from a factory usually cannot be used in your own paid advertising — a restriction that catches brands during their first paid campaign.
10. Regulatory Registration: Who Holds What
| Model | Typical Registration Holder | Practical Consequence | Risk Level |
|---|---|---|---|
| White label | Factory or an importing intermediary | You cannot move supplier without re-registering | High |
| Private label | Often the factory, sometimes your local sponsor | Access depends on the relationship continuing | Medium |
| Contract manufacturing | You, or a sponsor accountable to you | Registration travels with your business | Low |
The single most valuable question to ask before signing: "Whose name will appear on the registration certificate in each market?" If the answer is a factory, a distributor, or any entity you do not control, understand exactly what that means before you commit marketing spend behind the brand.
Why this is a commercial issue rather than a paperwork issue: a registration held by a third party gives that party effective control over your market access. In a dispute, or if the relationship ends, your ability to keep selling depends on their cooperation. Brands have lost entire markets this way.
What good looks like: the registration is held in your own name, or by a local sponsor under a written agreement that specifies term, transfer conditions, and the circumstances in which the registration must be released to you. Establish this at the outset — moving a registration later is materially harder than placing it correctly the first time.
11. Which Model Fits Which Brand Stage
| Brand Stage | Annual Volume | Recommended Model | Rationale |
|---|---|---|---|
| Pre-launch validation | Under 10,000 boxes | White label | Validate demand before committing development capital |
| Early traction | 10,000–30,000 boxes | Private label with stock packaging | Build differentiation while keeping tooling costs low |
| Established brand | 30,000–60,000 boxes | Private label with full custom packaging | Own the shelf presence and defend price points |
| Scaling brand | 60,000–150,000 boxes | Contract manufacturing | Margin advantage now exceeds development cost |
| Market leader | 150,000+ boxes | Contract manufacturing with dual sourcing | Protect supply security and formulation exclusivity |
Where most brands actually start, and should not: contract manufacturing at pre-launch. It is the most common expensive mistake in this category — a bespoke product built for a market that has not yet been tested, using capital that would have funded twelve months of marketing.
Where most brands stop too early: remaining on white label after reaching meaningful volume. The margin left on the table at 50,000 boxes per year is typically USD 10,000–20,000 annually, which is more than the cost of moving to private label.
12. Transitioning Between Models
| Transition | What Changes | Typical Cost and Time | Key Risk |
|---|---|---|---|
| White label to private label | New artwork, new packaging tooling, possibly new pack sizes | USD 2,500–7,000 / 6–10 weeks | Marketplace listing changes may reset review momentum |
| Private label to contract manufacturing | New formulation, new stability data, new registration, new tooling | USD 12,000–35,000 / 3–6 months | Regulatory re-submission and possible listing interruption |
| Changing suppliers within a model | New technical file, new samples, new tooling | USD 5,000–20,000 / 8–16 weeks | Registration held by the previous supplier may not transfer |
| Adding a second source | Duplicate tooling, parallel qualification | USD 8,000–25,000 / 3–5 months | Minor specification differences can require label changes |
The transition that must be planned earliest is registration. If your current registration is held by a factory or distributor, moving to a new model requires either their cooperation to transfer it or a fresh submission. Plan 3–6 months and budget for the regulatory cost. Brands that discover this late often delay a transition by a full year.
Protecting existing marketplace momentum: where possible, keep the ASIN or listing live by shipping the new configuration under the same product identity, and change packaging in a subsequent production run rather than simultaneously. Sudden specification changes can trigger marketplace review and interrupt ranking.
The sequencing rule: qualify the new product and registration completely before ending the old supply relationship. Running both in parallel for one or two cycles costs a little working capital and removes almost all transition risk.
13. Seven Mistakes That Cost Brands a Year
- Starting with contract manufacturing before proving demand. The most expensive mistake in the category — bespoke development, bespoke tooling, and registration costs committed before a single marketplace sale.
- Assuming white label exclusivity exists. It almost never does. If exclusivity matters to your business, it must be written into a contract, and it usually requires a volume commitment in exchange.
- Not asking who holds the registration. Discovering in year two that a distributor controls your market access is a commercial crisis, not a paperwork issue.
- Paying for tooling without owning it. If you fund print plates or tooling, the contract must state they are your property and must be returned or destroyed on termination.
- Choosing a model based on unit price alone. The cheapest unit cost frequently comes with the weakest control, the shortest exclusivity, and the highest long-term cost.
- Switching models without a transition plan. Simultaneously changing supplier and packaging is the fastest way to interrupt marketplace ranking and lose accumulated review history.
- Staying on white label past the point where margin justifies investment. At 50,000 boxes per year, the unclaimed margin usually exceeds the entire cost of moving to private label.
14. FAQ: Private Label vs White Label vs Contract Manufacturing
Q1: What is the difference between private label and white label?
A: White label means you resell an existing finished product under your own brand. Private label means the product is configured to your specification — active concentrations, patch dimensions, pack count, packaging — while still using the factory's process platform and base recipe.
Q2: What is the difference between private label and OEM?
A: OEM is the broad term for manufacturing under another company's brand. Private label is one form of OEM. Contract manufacturing, where you own the formulation and technical file, is another.
Q3: Which model is cheapest to start?
A: White label, at roughly USD 1,500–5,000 to first sale. Private label typically requires USD 6,000–15,000, and contract manufacturing USD 10,000–35,000.
Q4: Can two brands sell the same white label product?
A: Yes, and they frequently do. Unless you have a written exclusivity agreement — which usually requires a volume commitment — the factory is free to supply the same product to your competitors.
Q5: What MOQ should I expect for private label?
A: 2,000–5,000 patches with stock packaging, rising to 5,000–10,000 with fully custom pouch and box tooling. MOQ is driven primarily by tooling amortisation rather than production efficiency.
Q6: At what volume does contract manufacturing become worthwhile?
A: Generally above 60,000 boxes per year the 10–15 percentage point margin advantage repays development within twelve months. Below about 30,000 boxes per year, private label usually delivers a better return on capital.
Q7: Who owns the trademark and packaging design in each model?
A: You own your trademark in all three models if you register it. Packaging design ownership varies — in private label, confirm in writing that print plates, tooling and artwork files are your property and must be returned or destroyed on termination.
Q8: Will the registration be in my name?
A: Not automatically. In white label it is typically the factory's or an intermediary's; in private label it is often shared; in contract manufacturing you can register in your own name. Always ask before signing.
Q9: How long does it take to switch from white label to private label?
A: 6–10 weeks and USD 2,500–7,000, covering artwork, packaging tooling and a production run. The main risk is marketplace listing changes affecting ranking momentum.
Q10: Can I start white label and move to contract manufacturing later?
A: Yes, and this is the sequence most successful brands follow. Plan the transition early, particularly the registration, because moving a registration held by a third party takes 3–6 months and needs their cooperation.
About Kangdi Medical — All Three Models Under One Roof
Kangdi Medical is a 37-year pain patch OEM/ODM manufacturer based in Henan, China. Daily output: 4,000,000 patches. Certified: ISO 13485, CE (MDR), FDA, GMP, OTC monograph compliant. We supply 60+ countries including the USA, UK, Germany, Australia, Brazil, Saudi Arabia, and 10+ EU member states.
What we offer across all three models:
- White label from 500 patches, using proven formulations with existing stability data
- Private label from 2,000–5,000 patches, with your artwork and packaging specification
- Contract manufacturing from 10,000 patches, with formulation ownership and technical file transfer
- Written tooling and artwork ownership terms in every private label and contract agreement
- Technical file preparation and transfer support for your own registration
- Volume-linked exclusivity terms for contract manufacturing clients
- Lead time: 15 days (samples) / 25–30 days (standard) / 10–20 weeks (contract development)
Not sure which model fits your stage? Request a model recommendation · Request a sample pack · Request the model comparison worksheet
© 2026 Kangdi Medical. This article is informational and does not constitute legal or regulatory advice. Confirm registration ownership, tooling rights and exclusivity terms with your own advisors before signing any manufacturing agreement. Last updated: 2026-09-30.